Clinical Associations of Mucus Plugging in Moderate to Severe Asthma

Rory Chan1, Chary Duraikannu2, Brian Lipworth1

  • 1Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, Scotland, United Kingdom.

Abstract

Insights

Mucus plugging in asthma is linked to worse lung function and more severe symptoms. Identifying these mucus plugs (MPs) can help predict asthma severity and guide treatment decisions.

Area of Science:

  • Pulmonary Medicine
  • Respiratory Research
  • Clinical Immunology

Background:

  • Mucus plugging is a known factor contributing to airway obstruction and symptoms in persistent asthma.
  • Understanding the phenotypic associations of mucus plugging is crucial for managing moderate to severe asthma.

Purpose of the Study:

  • To determine the phenotypic associations of mucus plugging (MPs) in patients with moderate to severe asthma in a real-world clinical setting.
  • To analyze the relationship between mucus plugging and type 2 biomarkers, spirometry, exacerbations, and asthma control.

Main Methods:

  • Mucus plugs (MPs) were identified using high-resolution computed tomography (HRCT) imaging and scored by a radiologist.
  • Analysis included 126 patients with moderate to severe asthma, assessing MP score against type 2 biomarkers, spirometry, exacerbation history, and asthma control prior to biologic therapy.

Main Results:

  • Asthma patients with MPs showed significantly worse spirometry (FEV1%, FEF25-75%, FEV1/FVC) and higher levels of type 2 biomarkers (blood eosinophils, FeNO, total IgE, Aspergillus fumigatus IgE).
  • More frequent severe exacerbations were also associated with the presence of MPs.
  • Adjusted analyses confirmed associations between MPs and FEV1/FVC, frequent exacerbations, blood eosinophils, total IgE, and A. fumigatus IgE titers.

Conclusions:

  • Mucus plugging in poorly controlled asthma correlates with worse airflow obstruction and increased type 2 inflammation.
  • Factors such as impaired spirometry, frequent exacerbations, elevated blood eosinophils, total IgE, and A. fumigatus IgE increase the likelihood of mucus plugging.

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
533
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
345
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
405